{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T06:46:03Z","timestamp":1784184363320,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":334,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiovascular Magnetic Resonance"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1186\/s12968-022-00898-6","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T20:02:47Z","timestamp":1669838567000},"page":"67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathy"],"prefix":"10.1016","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8297-4025","authenticated-orcid":false,"given":"Michael B.","family":"Stokes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Thoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J.","family":"Scherer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyi T.H.","family":"Win","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen S.","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanthan","family":"Sanders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1186\/s12968-022-00898-6_bib1","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.cardfail.2019.10.002","article-title":"Clinical characteristics and outcomes of patients with heart failure and methamphetamine abuse","volume":"26","author":"Thomas","year":"2020","journal-title":"J Card Fail"},{"issue":"11","key":"10.1186\/s12968-022-00898-6_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016704","article-title":"Clinical characteristics and management of methamphetamine-associated cardiomyopathy: state-of-the-art review","volume":"9","author":"Reddy","year":"2020","journal-title":"J Am Heart Assoc"},{"issue":"3","key":"10.1186\/s12968-022-00898-6_bib3","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jchf.2017.10.006","article-title":"Clinical characteristics and outcome of methamphetamine-associated pulmonary arterial hypertension and dilated cardiomyopathy","volume":"6","author":"Zhao","year":"2018","journal-title":"JACC Heart Fail"},{"issue":"2","key":"10.1186\/s12968-022-00898-6_bib4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amjmed.2006.01.024","article-title":"The association of methamphetamine use and cardiomyopathy in young patients","volume":"120","author":"Yeo","year":"2007","journal-title":"Am J Med"},{"issue":"6","key":"10.1186\/s12968-022-00898-6_bib5","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.jchf.2017.02.017","article-title":"Clinical characteristics, histopathological features, and clinical outcome of methamphetamine-associated cardiomyopathy","volume":"5","author":"Sch\u00fcrer","year":"2017","journal-title":"JACC Heart Failure."},{"issue":"16","key":"10.1186\/s12968-022-00898-6_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018370","article-title":"Methamphetamine-associated heart failure hospitalizations across the United States: geographic and social disparities","volume":"10","author":"Dickson","year":"2021","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"10.1186\/s12968-022-00898-6_bib7","doi-asserted-by":"crossref","first-page":"E18","DOI":"10.1002\/clc.20367","article-title":"A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse","volume":"32","author":"Ito","year":"2009","journal-title":"Clin Cardiol"},{"issue":"8","key":"10.1186\/s12968-022-00898-6_bib8","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/j.ajem.2018.01.001","article-title":"Methamphetamine use and heart failure: prevalence, risk factors, and predictors","volume":"36","author":"Richards","year":"2018","journal-title":"Am J Emerg Med"},{"issue":"1502","key":"10.1186\/s12968-022-00898-6_bib9","first-page":"55","article-title":"Poor outcomes in methamphetamine-associated cardiomyopathy-a growing health issue in New Zealand","volume":"132","author":"Wang","year":"2019","journal-title":"N Z Med J"},{"issue":"7","key":"10.1186\/s12968-022-00898-6_bib10","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1081\/CLT-120026521","article-title":"Crystal methamphetamine-associated cardiomyopathy: tip of the iceberg?","volume":"41","author":"Wijetunga","year":"2003","journal-title":"J Toxicol Clin Toxicol"},{"issue":"1","key":"10.1186\/s12968-022-00898-6_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/1532-429X-11-46","article-title":"Recovery of methamphetamine associated cardiomyopathy predicted by late gadolinium enhanced cardiovascular magnetic resonance","volume":"11","author":"Lopez","year":"2009","journal-title":"J Cardiovasc Magn Reson"},{"issue":"11","key":"10.1186\/s12968-022-00898-6_bib12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jchf.2017.08.009","article-title":"Magnetic resonance as an alternative to endomyocardial biopsy to predict recoverability of left ventricular function in methamphetamine-associated cardiomyopathy","volume":"5","author":"Pujol-L\u00f3pez","year":"2017","journal-title":"JACC Heart Failure."},{"issue":"1","key":"10.1186\/s12968-022-00898-6_bib13","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0379-0738(95)01765-B","article-title":"Cardiac lesions and their reversibility after long term administration of methamphetamine","volume":"75","author":"Islam","year":"1995","journal-title":"Forensic Sci Int"},{"issue":"1","key":"10.1186\/s12968-022-00898-6_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s12968-017-0327-9","article-title":"Reference ranges for cardiac structure and function using cardiovascular magnetic resonance (CMR) in Caucasians from the UK Biobank population cohort","volume":"19","author":"Petersen","year":"2017","journal-title":"J Cardiovasc Magn Reson"},{"issue":"1","key":"10.1186\/s12968-022-00898-6_bib15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1532-429X-14-54","article-title":"Diagnostic and prognostic value of cardiovascular magnetic resonance in non-ischaemic cardiomyopathies","volume":"14","author":"Parsai","year":"2012","journal-title":"J Cardiovasc Magn Reson"},{"issue":"25","key":"10.1186\/s12968-022-00898-6_bib16","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1016\/j.jacc.2016.03.590","article-title":"The diagnosis and evaluation of dilated cardiomyopathy","volume":"67","author":"Japp","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1186\/s12968-022-00898-6_bib17","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1093\/eurjhf\/hfq161","article-title":"Relationship between right ventricular volumes measured by cardiac magnetic resonance imaging and prognosis in patients with chronic heart failure","volume":"13","author":"Bourantas","year":"2011","journal-title":"Eur J Heart Fail"},{"issue":"6","key":"10.1186\/s12968-022-00898-6_bib18","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1093\/eurjhf\/hft019","article-title":"Clinical utility and prognostic value of left atrial volume assessment by cardiovascular magnetic resonance in non-ischaemic dilated cardiomyopathy","volume":"15","author":"Gulati","year":"2013","journal-title":"Eur J Heart Fail"},{"issue":"1","key":"10.1186\/s12968-022-00898-6_bib19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s12012-016-9385-8","article-title":"Exposure to amphetamines leads to development of amphetamine type stimulants associated cardiomyopathy (ATSAC)","volume":"17","author":"Giv","year":"2017","journal-title":"Cardiovasc Toxicol"},{"issue":"9","key":"10.1186\/s12968-022-00898-6_bib20","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/ATVBAHA.119.312461","article-title":"Methamphetamine use and cardiovascular disease","volume":"39","author":"Kevil","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1186\/s12968-022-00898-6_bib21","first-page":"E89","article-title":"Methamphetamine-associated acute myocardial infarction and cardiogenic shock with normal coronary arteries: refractory global coronary microvascular spasm","volume":"19","author":"Chen","year":"2007","journal-title":"J Invasive Cardiol"},{"issue":"2","key":"10.1186\/s12968-022-00898-6_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00000433-199606000-00014","article-title":"Cardiac muscle lesions associated with chronic administration of methamphetamine in rats","volume":"17","author":"He","year":"1996","journal-title":"Am J Forensic Med Pathol"},{"issue":"1","key":"10.1186\/s12968-022-00898-6_bib23","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/cvr\/cvq043","article-title":"Oxidative stress contributes to methamphetamine-induced left ventricular dysfunction","volume":"87","author":"Lord","year":"2010","journal-title":"Cardiovasc Res"},{"issue":"1\u20133","key":"10.1186\/s12968-022-00898-6_bib24","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.forsciint.2011.04.028","article-title":"The unique histology of methamphetamine cardiomyopathy: a case report","volume":"212","author":"Karch","year":"2011","journal-title":"Forensic Sci Int"},{"issue":"5","key":"10.1186\/s12968-022-00898-6_bib25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.hrthm.2014.01.014","article-title":"Impact of the presence and amount of myocardial fibrosis by cardiac magnetic resonance on arrhythmic outcome and sudden cardiac death in nonischemic dilated cardiomyopathy","volume":"11","author":"Perazzolo Marra","year":"2014","journal-title":"Heart Rhythm"},{"issue":"7","key":"10.1186\/s12968-022-00898-6_bib26","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.jacc.2010.06.062","article-title":"Myocardial fibrosis predicts appropriate device therapy in patients with implantable cardioverter-defibrillators for primary prevention of sudden cardiac death","volume":"57","author":"Iles","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"10.1186\/s12968-022-00898-6_bib27","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1161\/CIRCIMAGING.113.001144","article-title":"Late gadolinium enhancement on cardiac magnetic resonance predicts adverse cardiovascular outcomes in nonischemic cardiomyopathy: a systematic review and meta-analysis","volume":"7","author":"Kuruvilla","year":"2014","journal-title":"Circ Cardiovasc Imaging"},{"issue":"5","key":"10.1186\/s12968-022-00898-6_bib28","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1093\/eurheartj\/ehr391","article-title":"Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography","volume":"33","author":"Leong","year":"2012","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1186\/s12968-022-00898-6_bib29","doi-asserted-by":"crossref","first-page":"520","DOI":"10.21037\/atm-20-7839","article-title":"Management of left ventricular thrombus: a narrative review","volume":"9","author":"Cruz Rodriguez","year":"2021","journal-title":"Ann Transl Med"}],"container-title":["Journal of Cardiovascular Magnetic Resonance"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12968-022-00898-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12968-022-00898-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664723012097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1097664723012097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12968-022-00898-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T05:20:21Z","timestamp":1769577621000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1097664723012097"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S1097664723012097"],"URL":"https:\/\/doi.org\/10.1186\/s12968-022-00898-6","relation":{},"ISSN":["1097-6647"],"issn-type":[{"value":"1097-6647","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular magnetic resonance imaging characteristics in patients with methamphetamine-associated cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiovascular Magnetic Resonance","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1186\/s12968-022-00898-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2022 THE AUTHORS. Published by Elsevier Inc on behalf of the Society for Cardiovascular Magnetic Resonance","name":"copyright","label":"Copyright"}],"article-number":"67"}}